Patents by Inventor Ramon E. Parsons

Ramon E. Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING PTEN-MUTANT TUMORS
    Publication number: 20250302817
    Abstract: Methods for assessing the efficacy of dihydroorotate dehydrogenase inhibitors in the treatment of cancer and methods of using such inhibitors to treat PTEN-mutant cancer are provided.
    Type: Application
    Filed: November 11, 2024
    Publication date: October 2, 2025
    Inventors: Ramon E. Parsons, Deepti Mathur, Ilias Stratikopoulos
  • SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE
    Publication number: 20230167106
    Abstract: Disclosed herein are serine threonine kinase (AKT) degradation/disruption compounds including an AKT ligand, a degradation/disruption tag, and a linker, and methods of using such compounds in the treatment of AKT-mediated diseases.
    Type: Application
    Filed: October 6, 2022
    Publication date: June 1, 2023
    Inventors: Jian Jin, Jing Liu, Ramon E. Parsons, Jia Xu, Xufen Yu
  • Serine threonine kinase (AKT) degradation / disruption compounds and methods of use
    Patent number: 11472799
    Abstract: Disclosed herein are serine threonine kinase (AKT) degradation/disruption compounds including an AKT ligand, a degradation/disruption tag, and a linker, and methods of using such compounds in the treatment of AKT-mediated diseases.
    Type: Grant
    Filed: March 6, 2019
    Date of Patent: October 18, 2022
    Assignee: Icahn School of Medicine at Mount Sinai
    Inventors: Jian Jin, Jing Liu, Ramon E. Parsons, Jia Xu, Xufen Yu
  • SERINE THREONINE KINASE (AKT) DEGRADATION / DISRUPTION COMPOUNDS AND METHODS OF USE
    Publication number: 20200399266
    Abstract: Disclosed herein are serine threonine kinase (AKT) degradation/disruption compounds including an AKT ligand, a degradation/disruption tag, and a linker, and methods of using such compounds in the treatment of AKT-mediated diseases.
    Type: Application
    Filed: March 6, 2019
    Publication date: December 24, 2020
    Inventors: Jian Jin, Jing Liu, Ramon E. Parsons, Jia Xu, Xufen Yu